Heterodimerization of G protein-coupled receptors: Specificity and functional significance

Pharmacological Reviews

Volumn 57, Issue 3, 2005, Pages 289-298

  Prinster, Steven C ^a   Hague, Chris ^a   Hall, Randy A ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR; ADRENALIN; ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; G PROTEIN COUPLED RECEPTOR; NORADRENALIN; OLIGOMER; OPIATE RECEPTOR; OXYTOCIN; PURINE RECEPTOR; RECEPTOR SUBTYPE; SOMATOSTATIN RECEPTOR; VASOPRESSIN;

ADRENERGIC SYSTEM; DIMERIZATION; GABAERGIC SYSTEM; HUMAN; OLFACTORY RECEPTOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SURFACE PROPERTY; TASTE;

ANIMALS; DIMERIZATION; DRUG DESIGN; HUMANS; LIGANDS; PROTEIN TRANSPORT; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION;

EID: 23944501304     PISSN: 00316997     EISSN: None     Source Type: Journal    
DOI: 10.1124/pr.57.3.1     Document Type: Review

References (141)

1. AbdAlla S, Lother H, Abdel-tawab AM, and Quitterer U (2001a) The angiotensin II AT2 receptor is an AT1 receptor antagonist. J Biol Chem 276:39721-39726.
2. AbdAlla S, Lother H, el Massiery A, and Quitterer U (2001b) Increased AT(1) receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness. Nat Med 7:1003-1009.
3. AbdAlla S, Lother H, and Quitterer U (2000) AT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration. Nature (Lond) 407:94-98.
4. Abdelhamid EE, Sultana M, Portoghese PS, and Takemori AE (1991) Selective blockage of delta opioid receptors prevents the development of morphine tolerance and dependence in mice. J Pharmacol Exp Ther 258:299-303.
5. Agnati LF, Ferre S, Lluis C, Franco R, and Fuxe K (2003) Molecular mechanisms and therapeutical implications of intramembrane receptor/receptor interactions among heptahelical receptors with examples from the striatopallidal GABA neurons. Pharmacol Rev 55:509-550.
6. Agnati LF, Fuxe K, Zoli M, Rondanini C, and Ogren SO (1982) New vistas on synaptic plasticity: the receptor mosaic hypothesis of the engram. Med Biol 60:183-190.
7. Angers S, Salahpour A, and Bouvier M (2002) Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function. Annu Rev Pharmacol Toxicol 42:409-435.
8. Angers S, Salahpour A, Joly E, Hilairet S, Chelsky D, Dennis M, and Bouvier M (2000) Detection of beta 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET). Proc Natl Acad Sci USA 97:3684-3689.
9. Ayoub MA, Couturier C, Lucas-Meunier E, Angers S, Fossier P, Bouvier M, and Jockers R (2002) Monitoring of ligand-independent dimerization and ligandinduced conformational changes of melatonin receptors in living cells by bioluminescence resonance energy transfer. J Biol Chem 277:21522-21528.
10. Ayoub MA, Levoye A, Delagrange P, and Jockers R (2004) Preferential formation of MT1/MT2 melatonin receptor heterodimers with distinct ligand interaction properties compared with MT2 homodimers. Mol Pharmacol 66:312-321.
11. Bachmanov AA, Li X, Reed DR, Ohmen JD, Li S, Chen Z, Tordoff MG, de Jong PJ, Wu C, West DB, et al. (2001) Positional cloning of the mouse saccharin preference (Sac) locus. Chem Senses 26:925-933.
12. Balasubramanian S, Teissere JA, Raju DV, and Hall RA (2004) Heterooligomerization between GABAA and GABAB receptors regulates GABAB receptor trafficking. J Biol Chem 279:18840-18850.
13. Barki-Harrington L, Luttrell LM, and Rockman HA (2003) Dual inhibition of betaadrenergic and angiotensin II receptors by a single antagonist: a functional role for receptor-receptor interaction in vivo. Circulation 108:1611-1618.
14. Breit A, Lagace M, and Bouvier M (2004) Hetero-oligomerization between beta2- and beta3-adrenergic receptors generates a beta-adrenergic signaling unit with distinct functional properties. J Biol Chem 279:28756-28765.
15. Buck L and Axel R (1991) A novel multigene family may encode odorant receptors: a molecular basis for odor recognition. Cell 65:175-187.
16. Cairns JS and D'Souza MP (1998) Chemokines and HIV-1 second receptors: the therapeutic connection. Nat Med 4:563-568.
17. Calver AR, Medhurst AD, Robbins MJ, Charles KJ, Evans ML, Harrison DC, Stammers M, Hughes SA, Hervieu G, Couve A, et al. (2000) The expression of GABA(B1) and GABA(B2) receptor subunits in the CNS differs from that in peripheral tissues. Neuroscience 100:155-170.
18. Calver AR, Robbins MJ, Cosio C, Rice SQ, Babbs AJ, Hirst WD, Boyfield I, Wood MD, Russell RB, Price GW, et al. (2001) The C-terminal domains of the GABA(b) receptor subunits mediate intracellular trafficking but are not required for receptor signaling. J Neurosci 21:1203-1210.
19. Canals M, Marcellino D, Fanelli F, Ciruela F, de Benedetti P, Goldberg SR, Neve K, Fuxe K, Agnati LF, Woods AS, et al. (2003) Adenosine A2A-dopamine D2 receptorreceptor heteromerization: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer. J Biol Chem 278:46741-46749.
20. Carrillo JJ, Pediani J, and Milligan G (2003) Dimers of class A G protein-coupled receptors function via agonist-mediated trans-activation of associated G proteins. J Biol Chem 278:42578-42587.
21. Chalothorn D, McCune DF, Edelmann SE, Garcia-Cazarin ML, Tsujimoto G, and Piascik MT (2002) Differences in the cellular localization and agonist-mediated internalization properties of the alpha(1)-adrenoceptor subtypes. Mol Pharmacol 61:1008-1016.
22. Charara A, Galvan A, Kuwajima M, Hall RA, and Smith Y (2004) An electron microscope immunocytochemical study of GABA(B) R2 receptors in the monkey basal ganglia: a comparative analysis with GABA(B) R1 receptor distribution. J Comp Neurol 476:65-79.
23. Chen C, Li J, Bot G, Szabo I, Rogers TJ, and Liu-Chen LY (2004) Heterodimerization and cross-desensitization between the mu-opioid receptor and the chemokine CCR5 receptor. Eur J Pharmacol 483:175-186.
24. Cheng ZJ, Harikumar KG, Holicky EL, and Miller LJ (2003) Heterodimerization of type A and B cholecystokinin receptors enhance signaling and promote cell growth. J Biol Chem 278:52972-52979.
25. Chneiweiss H, Glowinski J, and Premont J (1985) Modulation by monoamines of somatostatin-sensitive adenylate cyclase on neuronal and glial cells from the mouse brain in primary cultures. J Neurochem 44:1825-1831.
26. Ciruela F, Escriche M, Burgueno J, Angulo E, Casado V, Soloviev MM, Canela EI, Mallol J, Chan WY, Lluis C, et al. (2001) Metabotropic glutamate 1alpha and adenosine A1 receptors assemble into functionally interacting complexes. J Biol Chem 276:18345-18351.
27. Claing A, Laporte SA, Caron MG, and Lefkowitz RJ (2002) Endocytosis of G proteincoupled receptors: roles of G protein-coupled receptor kinases and beta-arrestin proteins. Prog Neurobiol 66:61-79.
28. Clark JA, Mezey E, Lam AS, and Bonner TI (2000) Distribution of the GABA(B) receptor subunit gb2 in rat CNS. Brain Res 860:41-52.
29. Couve A, Filippov AK, Connolly CN, Bettler B, Brown DA, and Moss SJ (1998) Intracellular retention of recombinant GABAB receptors. J Biol Chem 273:26361-26367.
30. Cvejic S and Devi LA (1997) Dimerization of the delta opioid receptor: implication for a role in receptor internalization. J Biol Chem 272:26959-26964.
31. Devost D and Zingg HH (2004) Homo- and hetero-dimeric complex formations of the human oxytocin receptor. J Neuroendocrinol 16:372-377.
32. Drews J (1996) Genomic sciences and the medicine of tomorrow. Nat Biotechnol 14:1516-1518.
33. Durkin MM, Gunwaldsen CA, Borowsky B, Jones KA, and Branchek TA (1999) An in situ hybridization study of the distribution of the GABA(B2) protein mRNA in the rat CNS. Brain Res Mol Brain Res 71:185-200.
34. Ferre S, Ciruela F, Canals M, Marcellino D, Burgueno J, Casado V, Hillion J, Torvinen M, Fanelli F, Benedetti Pd P, et al. (2004) Adenosine A2A-dopamine D2 receptor-receptor heteromers. Targets for neuro-psychiatric disorders. Parkinsonism Relat Disord 10:265-271.
35. Ferre S, Karcz-Kubicha M, Hope BT, Popoli P, Burgueno J, Gutierrez MA, Casado V, Fuxe K, Goldberg SR, Lluis C, et al. (2002) Synergistic interaction between adenosine A2A and glutamate mGlu5 receptors: implications for striatal neuronal function. Proc Natl Acad Sci USA 99:11940-11945.
36. Franco R, Ferre S, Agnati L, Torvinen M, Gines S, Hillion J, Casado V, Lledo P, Zoli M, Lluis C, and Fuxe K (2000) Evidence for adenosine/dopamine receptor interactions: indications for heteromerization. Neuropsychopharmacology 23 (Suppl 4):S50-S59.
37. Gama L, Wilt SG, and Breitwieser GE (2001) Heterodimerization of calcium sensing receptors with metabotropic glutamate receptors in neurons. J Biol Chem 276:39053-39059.
38. George SR, Fan T, Xie Z, Tse R, Tam V, Varghese G, and O'Dowd BF (2000) Oligomerization of mu- and delta-opioid receptors. Generation of novel functional properties. J Biol Chem 275:26128-26135.
39. George SR, O'Dowd BF, and Lee SP (2002) G-protein-coupled receptor oligomerization and its potential for drug discovery. Nat Rev Drug Discov 1:808-820.
40. Gines S, Hillion J, Torvinen M, Le Crom S, Casado V, Canela EI, Rondin S, Lew JY, Watson S, Zoli M, et al. (2000) Dopamine D1 and adenosine A1 receptors form functionally interacting heteromeric complexes. Proc Natl Acad Sci USA 97:8606-8611.
41. Gomes I, Gupta A, Filipovska J, Szeto HH, Pintar JE, and Devi LA (2004) A role for heterodimerization of mu and delta opiate receptors in enhancing morphine analgesia. Proc Natl Acad Sci USA 101:5135-5139.
42. Gomes I, Jordan BA, Gupta A, Trapaidze N, Nagy V, and Devi LA (2000) Heterodimerization of mu and delta opioid receptors: a role in opiate synergy. J Neurosci 20:RC110.
43. Grant M, Collier B, and Kumar U (2004a) Agonist-dependent dissociation of human somatostatin receptor 2 dimers: a role in receptor trafficking. J Biol Chem 279: 36179-36183.
44. Grant M, Patel RC, and Kumar U (2004b) The role of subtype-specific ligand binding and the C-tail domain in dimer formation of human somatostatin receptors. J Biol Chem 279:38636-38643.
45. Gregan B, Jurgensen J, Papsdorf G, Furkert J, Schaefer M, Beyermann M, Rosenthal W, and Oksche A (2004) Ligand-dependent differences in the internalization of endothelin A and endothelin B receptor heterodimers. J Biol Chem 279:27679-27687.
46. Hague C, Uberti MA, Chen Z, Bush CF, Jones SV, Ressler KJ, Hall RA, and Minneman KP (2004a) Olfactory receptor surface expression is driven by association with the beta2-adrenergic receptor. Proc Natl Acad Sci USA 101:13672-13676.
47. Hague C, Uberti MA, Chen Z, Hall RA, and Minneman KP (2004b) Cell surface expression of alpha 1D-adrenergic receptors is controlled by heterodimerization with alpha 1B-adrenergic receptors. J Biol Chem 279:15541-15549.
48. Hanyaloglu AC, Seeber RM, Kohout TA, Lefkowitz RJ, and Eidne KA (2002) Homo-and hetero-oligomerization of thyrotropin-releasing hormone (TRH) receptor subtypes. Differential regulation of beta-arrestins 1 and 2. J Biol Chem 277:50422-50430.
49. Havlicek V, Rezek M, and Friesen H (1976) Somatostatin and thyrotropin releasing hormone: central effect on sleep and motor system. Pharmacol Biochem Behav 4:455-459.
50. He L, Fong J, von Zastrow M, and Whistler JL (2002) Regulation of opioid receptor trafficking and morphine tolerance by receptor oligomerization. Cell 108:271-282.
51. He L and Lee NM (1998) Delta opioid receptor enhancement of mu opioid receptorinduced antinociception in spinal cord. J Pharmacol Exp Ther 285:1181-1186.
52. Hebert TE, Loisel TP, Adam L, Ethier N, Onge SS, and Bouvier M (1998) Functional rescue of a constitutively desensitized beta2AR through receptor dimerization. Biochem J 330:287-293.
53. Hebert TE, Moffett S, Morello JP, Loisel TP, Bichet DG, Barret C, and Bouvier M (1996) A peptide derived from a beta2-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation. J Biol Chem 271:16384-16392.
54. Heyman JS, Vaught JL, Mosberg HI, Haaseth RC, and Porreca F (1989) Modulation of mu-mediated antinociception by delta agonists in the mouse: selective potentiation of morphine and normorphine by [D-Pen2,D-Pen5]enkephalin. Eur J Pharmacol 165:1-10.
55. Hillion J, Canals M, Torvinen M, Casado V, Scott R, Terasmaa A, Hansson A, Watson S, Olah ME, Mallol J, et al. (2002) Coaggregation, cointernalization and codesensitization of adenosine A2A receptors and dopamine D2 receptors. J Biol Chem 277:18091-18097.
56. Hirasawa A, Sugawara T, Awaji T, Tsumaya K, Ito H, and Tsujimoto G (1997) Subtype-specific differences in subcellular localization of alpha1-adrenoceptors: chlorethylclonidine preferentially alkylates the accessible cell surface alpha1-adrenoceptors irrespective of the subtype. Mol Pharmacol 52:764-770.
57. Hoon MA, Adler E, Lindemeier J, Battey JF, Ryba NJ, and Zuker CS (1999) Putative mammalian taste receptors: a class of taste-specific GPCRs with distinct topographic selectivity. Cell 96:541-551.
58. Horan P, Tallarida RJ, Haaseth RC, Matsunaga TO, Hruby VJ, and Porreca F (1992) Antinociceptive interactions of opioid delta receptor agonists with morphine in mice: supra- and sub-additivity. Life Sci 50:1535-1541.
59. Ige AO, Bolam JP, Billinton A, White JH, Marshall FH, and Emson PC (2000) Cellular and sub-cellular localisation of GABA(B1) and GABA(B2) receptor proteins in the rat cerebellum. Brain Res Mol Brain Res 83:72-80.
60. Izquierdo-Claros RM, Boyano-Adanez MC, Larsson C, Gustavsson L, and Arilla E (1997) Acute effects of D1- and D2-receptor agonist and antagonist drugs on somatostatin binding, inhibition of adenylyl cyclase activity and accumulation of inositol 1,4,5-trisphosphate in the rat striatum. Brain Res Mol Brain Res 47:99-107.
61. Jones KA, Borowsky B, Tamm JA, Craig DA, Durkin MM, Dai M, Yao WJ, Johnson M, Gunwaldsen C, Huang LY, et al. (1998) GABA(B) receptors function as a heteromeric assembly of the subunits GABA(B)R1 and GABA(B)R2. Nature (Lond) 396:674-679.
62. Jordan BA, Cvejic S, and Devi LA (2000) Opioids and their complicated receptor complexes. Neuropsychopharmacology 23 (Suppl 4):S5-S18.
63. Jordan BA and Devi LA (1999) G-protein-coupled receptor heterodimerization modulates receptor function. Nature (Lond) 399:697-700.
64. Jordan BA, Gomes I, Rios C, Filipovska J, and Devi LA (2003) Functional interactions between mu opioid and alpha 2A-adrenergic receptors. Mol Pharmacol 64:1317-1324.
65. Jordan BA, Trapaidze N, Gomes I, Nivarthi R, and Devi LA (2001) Oligomerization of opioid receptors with beta 2-adrenergic receptors: a role in trafficking and mitogen-activated protein kinase activation. Proc Natl Acad Sci USA 98:343-348.
66. Kamiya T, Saitoh O, Yoshioka K, and Nakata H (2003) Oligomerization of adenosine A2A and dopamine D2 receptors in living cells. Biochem Biophys Res Commun 306:544-549.
67. Kaupmann K, Huggel K, Heid J, Flor PJ, Bischoff S, Mickel SJ, McMaster G, Angst C, Bittiger H, Froestl W, and Bettler B (1997) Expression cloning of GABA(B) receptors uncovers similarity to metabotropic glutamate receptors. Nature (Lond) 386:239-246.
68. Kaupmann K, Malitschek B, Schuler V, Heid J, Froestl W, Beck P, Mosbacher J, Bischoff S, Kulik A, Shigemoto R, et al. (1998) GABA(B)-receptor subtypes assemble into functional heteromeric complexes. Nature (Lond) 396:683-687.
69. Kaykas A, Yang-Snyder J, Heroux M, Shah KV, Bouvier M, and Moon RT (2004) Mutant Frizzled 4 associated with vitreoretinopathy traps wild-type Frizzled in the endoplasmic reticulum by oligomerization. Nat Cell Biol 6:52-58.
70. Kitagawa M, Kusakabe Y, Miura H, Ninomiya Y, and Hino A (2001) Molecular genetic identification of a candidate receptor gene for sweet taste. Biochem Biophys Res Commun 283:236-242.
71. Kroeger KM, Pfleger KD, and Eidne KA (2003) G-protein coupled receptor oligomerization in neuroendocrine pathways. Front Neuroendocrinol. 24:254-278.
72. Kuner R, Kohr G, Grunewald S, Eisenhardt G, Bach A, and Kornau HC (1999) Role of heteromer formation in GABAB receptor function. Science (Wash DC) 283:74-77.
73. Lahlou H, Guillermet J, Hortala M, Vernejoul F, Pyronnet S, Bousquet C, and Susini C (2004) Molecular signaling of somatostatin receptors. Ann NY Acad Sci 1014:121-131.
74. Larsson MC, Domingos AI, Jones WD, Chiappe ME, Amrein H, and Vosshall LB (2004) Or83b encodes a broadly expressed odorant receptor essential for Drosophila olfaction. Neuron 43:703-714.
75. Lavoie C and Hebert TE (2003) Pharmacological characterization of putative beta1-beta2-adrenergic receptor heterodimers. Can J Physiol Pharmacol 81:186-195.
76. Lavoie C, Mercier JF, Salahpour A, Umapathy D, Breit A, Villeneuve LR, Zhu WZ, Xiao RP, Lakatta EG, Bouvier M, and Hebert TE (2002) Beta 1/beta 2-adrenergic receptor heterodimerization regulates beta 2-adrenergic receptor internalization and ERK signaling efficacy. J Biol Chem 277:35402-35410.
77. Lee B, Doranz BJ, Rana S, Yi Y, Mellado M, Frade JM, Martinez AC, O'Brien SJ, Dean M, Collman RG, and Doms RW (1998) Influence of the CCR2-V64I polymorphism on human immunodeficiency virus type 1 coreceptor activity and on chemokine receptor function of CCR2b, CCR3, CCR5 and CXCR4. J Virol 72:7450-7458.
78. Lee SP, So CH, Rashid AJ, Varghese GV, Cheng RC, Lanca AJ, O'Dowd BF, and George SR (2004) Dopamine D1 and D2 receptor co-activation generates a novel phospholipase C-mediated calcium signal. J Biol Chem 279:35671-35678.
79. Lefkowitz RJ, Cotecchia S, Samama P, and Costa T (1993) Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. Trends Pharmacol Sci 14:303-307.
80. Lu M, Echeverri F, and Moyer BD (2003) Endoplasmic reticulum retention, degradation and aggregation of olfactory G-protein coupled receptors. Traffic 4:416-433.
81. Maggio R, Barbier P, Colelli A, Salvadori F, Demontis G, and Corsini GU (1999) G protein-linked receptors: pharmacological evidence for the formation of heterodimers. J Pharmacol Exp Ther 291:251-257.
82. Maggio R, Scarselli M, Novi F, Millan MJ, and Corsini GU (2003) Potent activation of dopamine D3/D2 heterodimers by the antiparkinsonian agents, S32504, pramipexole and ropinirole. J Neurochem 87:631-641.
83. Maggio R, Vogel Z, and Wess J (1993) Coexpression studies with mutant muscarinic/adrenergic receptors provide evidence for intermolecular "cross-talk" between G-protein-linked receptors. Proc Natl Acad Sci USA 90:3103-3107.
84. Malmberg AB and Yaksh TL (1992) Isobolographic and dose-response analyses of the interaction between intrathecal mu and delta agonists: effects of naltrindole and its benzofuran analog (NTB). J Pharmacol Exp Ther 263:264-275.
85. Margeta-Mitrovic M, Mitrovic I, Riley RC, Jan LY, and Basbaum AI (1999) Immunohistochemical localization of GABA(B) receptors in the rat central nervous system. J Comp Neurol 405:299-321.
86. Marshall FH (2001) Heterodimerization of G-protein-coupled receptors in the CNS. Curr Opin Pharmacol 1:40-44.
87. Marshall FH, Jones KA, Kaupmann K, and Bettler B (1999) GABAB receptors-the first 7TM heterodimers. Trends Pharmacol Sci 20:396-399.
88. Martin SC, Russek SJ, and Farb DH (1999) Molecular identification of the human GABABR2: cell surface expression and coupling to adenylyl cyclase in the absence of GABABR1. Mol Cell Neurosci 13:180-191.
89. Marzullo P, Ferone D, Di Somma C, Pivonello R, Filippella M, Lombardi G, and Colao A (1999) Efficacy of combined treatment with lanreotide and cabergoline in selected therapy-resistant acromegalic patients. Pituitary 1:115-120.
90. Max M, Shanker YG, Huang L, Rong M, Liu Z, Campagne F, Weinstein H, Damak S, and Margolskee RF (2001) Tas1r3, encoding a new candidate taste receptor, is allelic to the sweet responsiveness locus Sac. Nat Genet 28:58-63.
91. McClintock TS, Landers TM, Gimelbrant AA, Fuller LZ, Jackson BA, Jayawickreme CK, and Lerner MR (1997) Functional expression of olfactory-adrenergic receptor chimeras and intracellular retention of heterologously expressed olfactory receptors. Brain Res Mol Brain Res 48:270-278.
92. McVey M, Ramsay D, Kellett E, Rees S, Wilson S, Pope AJ, and Milligan G (2001) Monitoring receptor oligomerization using time-resolved fluorescence resonance energy transfer and bioluminescence resonance energy transfer. The human deltaopioid receptor displays constitutive oligomerization at the cell surface, which is not regulated by receptor occupancy. J Biol Chem 276:14092-14099.
93. Mellado M, Rodriguez-Frade JM, Vila-Coro AJ, de Ana AM, and Martinez AC (1999) Chemokine control of HIV-1 infection. Nature (Lond) 400:723-724.
94. Mellado M, Rodriguez-Frade JM, Vila-Coro AJ, Fernandez S, Martin de Ana A, Jones DR, Toran JL, and Martinez AC (2001) Chemokine receptor homo- or heterodimerization activates distinct signaling pathways. EMBO (Eur Mol Biol Organ) J 20:2497-2507.
95. Mercier JF, Salahpour A, Angers S, Breit A, and Bouvier M (2002) Quantitative assessment of beta 1- and beta 2-adrenergic receptor homo- and heterodimerization by bioluminescence resonance energy transfer. J Biol Chem 277:44925-44931.
96. Milligan G (2004) G protein-coupled receptor dimerization: function and ligand pharmacology. Mol Pharmacol 66:1-7.
97. Moller LN, Stidsen CE, Hartmann B, and Holst JJ (2003) Somatostatin receptors. Biochim Biophys Acta 1616:1-84.
98. Mombaerts P (2004) Genes and ligands for odorant, vomeronasal and taste receptors. Nat Rev Neurosci 5:263-278.
99. Montmayeur JP, Liberles SD, Matsunami H, and Buck LB (2001) A candidate taste receptor gene near a sweet taste locus. Nat Neurosci 4:492-498.
100. Nelson G, Hoon MA, Chandrashekar J, Zhang Y, Ryba NJ, and Zuker CS (2001) Mammalian sweet taste receptors. Cell 106:381-390.
101. Neuhaus EM, Gisselmann G, Zhang W, Dooley R, Stortkuhl K, and Hatt H (2005) Odorant receptor heterodimerization in the olfactory system of Drosophila melanogaster. Nat Neurosci 8:15-17.
102. Ng GY, Clark J, Coulombe N, Ethier N, Hebert TE, Sullivan R, Kargman S, Chateauneuf A, Tsukamoto N, McDonald T, et al. (1999) Identification of a GABAB receptor subunit, gb2, required for functional GABAB receptor activity. J Biol Chem 274:7607-7610.
103. Pagano A, Rovelli G, Mosbacher J, Lohmann T, Duthey B, Stauffer D, Ristig D, Schuler V, Meigel I, Lampert C, et al. (2001) C-terminal interaction is essential for surface trafficking but not for heteromeric assembly of GABA(b) receptors. J Neurosci 21:1189-1202.
104. Patel RC, Kumar U, Lamb DC, Eid JS, Rocheville M, Grant M, Rani A, Hazlett T, Patel SC, Gratton E, and Patel YC (2002) Ligand binding to somatostatin receptors induces receptor-specific oligomer formation in live cells. Proc Natl Acad Sci USA 99:3294-3299.
105. Pepe S, van den Brink OW, Lakatta EG, and Xiao RP (2004) Cross-talk of opioid peptide receptor and beta-adrenergic receptor signalling in the heart. Cardiovasc Res 63:414-422.
106. Pepe S, Xiao RP, Hohl C, Altschuld R, and Lakatta EG (1997) 'Cross talk' between opioid peptide and adrenergic receptor signaling in isolated rat heart. Circulation 95:2122-2129.
107. Pfeiffer M, Kirscht S, Stumm R, Koch T, Wu D, Laugsch M, Schroder H, Hollt V, and Schulz S (2003) Heterodimerization of substance P and mu-opioid receptors regulates receptor trafficking and resensitization. J Biol Chem 278:51630-51637.
108. Pfeiffer M, Koch T, Schroder H, Klutzny M, Kirscht S, Kreienkamp HJ, Hollt V, and Schulz S (2001) Homo- and heterodimerization of somatostatin receptor subtypes. Inactivation of sst(3) receptor function by heterodimerization with sst(2A). J Biol Chem 276:14027-14036.
109. Pfeiffer M, Koch T, Schroder H, Laugsch M, Hollt V, and Schulz S (2002) Heterodimerization of somatostatin and opioid receptors cross-modulates phosphorylation, internalization and desensitization. J Biol Chem 277:19762-19772.
110. Porreca F, Takemori AE, Sultana M, Portoghese PS, Bowen WD, and Mosberg HI (1992) Modulation of mu-mediated antinociception in the mouse involves opioid delta-2 receptors. J Pharmacol Exp Ther 263:147-152.
111. Ralevic V and Burnstock G (1998) Receptors for purines and pyrimidines. Pharmacol Rev 50:413-492.
112. Ramsay D, Kellett E, McVey M, Rees S, and Milligan G (2002) Homo- and heterooligomeric interactions between G-protein-coupled receptors in living cells monitored by two variants of bioluminescence resonance energy transfer (BRET): hetero-oligomers between receptor subtypes form more efficiently than between less closely related sequences. Biochem J 365:429-440.
113. Robitaille J, MacDonald MLE, Kaykas A, Sheldahl LC, Zeisler J, Dube M-P, Zhang L-H, Singaraja RR, Guernsey DL, Zheng B, et al. (2002) Mutant frizzled-4 disrupts retinal angiogenesis in familial exudative vitreoretinopathy. Nat Genet 32:326-330.
114. Rocheville M, Lange DC, Kumar U, Patel SC, Patel RC, and Patel YC (2000a) Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity. Science (Wash DC) 288:154-157.
115. Rocheville M, Lange DC, Kumar U, Sasi R, Patel RC, and Patel YC (2000b) Subtypes of the somatostatin receptor assemble as functional homo- and heterodimers. J Biol Chem 275:7862-7869.
116. Rodriguez-Frade JM, del Real G, Serrano A, Hernanz-Falcon P, Soriano SF, Vila-Coro AJ, de Ana AM, Lucas P, Prieto I, Martinez AC, and Mellado M (2004) Blocking HIV-1 infection via CCR5 and CXCR4 receptors by acting in trans on the CCR2 chemokine receptor. EMBO (Eur Mol Biol Organ) J 23:66-76.
117. Sainz E, Korley JN, Battey JF, and Sullivan SL (2001) Identification of a novel member of the T1R family of putative taste receptors. J Neurochem 77:896-903.
118. Salahpour A, Angers S, Mercier JF, Lagace M, Marullo S, and Bouvier M (2004) Homomerization of the beta 2-adrenergic receptor as a pre-requisite for cell surface targeting. J Biol Chem 279:33390-33397.
119. Salim K, Fenton T, Bacha J, Urien-Rodriguez H, Bonnert T, Skynner HA, Watts E, Kerby J, Heald A, Beer M, et al. (2002) Oligomerization of G-protein-coupled receptors shown by selective co-immunoprecipitation. J Biol Chem 277:15482-15485.
120. Sanchez-Blazquez P, Garcia-Espana A, and Garzon J (1997) Antisense oligodeoxynucleotides to opioid mu and delta receptors reduced morphine dependence in mice: role of delta-2 opioid receptors. J Pharmacol Exp Ther 280:1423-1431.
121. Scarselli M, Novi F, Schallmach E, Lin R, Baragli A, Colzi A, Griffon N, Corsini GU, Sokoloff P, Levenson R, et al. (2001) D2/D3 dopamine receptor heterodimers exhibit unique functional properties. J Biol Chem 276:30308-30314.
122. Smith MW, Dean M, Carrington M, Winkler C, Huttley GA, Lomb DA, Goedert JJ, O'Brien TR, Jacobson LP, Kaslow R, et al. (1997) Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study. Science (Wash DC) 277:959-965.
123. Stanasila L, Perez JB, Vogel H, and Cotecchia S (2003) Oligomerization of the alpha 1a- and alpha 1b-adrenergic receptor subtypes. Potential implications in receptor internalization. J Biol Chem 278:40239-40251.
124. Sullivan R, Chateauneuf A, Coulombe N, Kolakowski LF Jr, Johnson MP, Hebert TE, Ethier N, Belley M, Metters K, Abramovitz M, et al. (2000) Coexpression of full-length gamma-aminobutyric acid(B) (GABA(B)) receptors with truncated receptors and metabotropic glutamate receptor 4 supports the GABA(B) heterodimer as the functional receptor. J Pharmacol Exp Ther 293:460-467.
125. Suzuki S, Chuang LF, Yau P, Doi RH, and Chuang RY (2002) Interactions of opioid and chemokine receptors: oligomerization of mu, kappa and delta with CCR5 on immune cells. Exp Cell Res 280:192-200.
126. Terrillon S, Barberis C, and Bouvier M (2004) Heterodimerization of V1a and V2 vasopressin receptors determines the interaction with {beta}-arrestin and their trafficking patterns. Proc Natl Acad Sci USA 101:1548-1553.
127. Terrillon S and Bouvier M (2004a) Receptor activity-independent recruitment of betaarrestin2 reveals specific signalling modes. EMBO (Eur Mol Biol Organ) J 23:3950-3961.
128. Terrillon S and Bouvier M (2004b) Roles of G-protein-coupled receptor dimerization. EMBO Rep 5:30-34.
129. Terrillon S, Durroux T, Mouillac B, Breit A, Ayoub MA, Taulan M, Jockers R, Barberis C, and Bouvier M (2003) Oxytocin and vasopressin V1a and V2 receptors form constitutive homo- and heterodimers during biosynthesis. Mol Endocrinol 17:677-691.
130. Theroux TL, Esbenshade TA, Peavy RD, and Minneman KP (1996) Coupling efficiencies of human alpha 1-adrenergic receptor subtypes: titration of receptor density and responsiveness with inducible and repressible expression vectors. Mol Pharmacol 50:1376-1387.
131. Uberti MA, Hague C, Oller H, Minneman KP, and Hall RA (2005) Heterodimerization with beta-2-adrenergic receptors promotes surface expression and functional activity of alpha-1D-adrenergic receptors. J Pharmacol Exp Ther 313:16-23.
132. Uberti MA, Hall RA, and Minneman KP (2003) Subtype-specific dimerization of alpha 1-adrenoceptors: effects on receptor expression and pharmacological properties. Mol Pharmacol 64:1379-1390.
133. Van Brocklyn JR, Behbahani B, and Lee NH (2002) Homodimerization and heterodimerization of S1P/EDG sphingosine-1-phosphate receptors. Biochim Biophys Acta 1582:89-93.
134. White JH, Wise A, Main MJ, Green A, Fraser NJ, Disney GH, Barnes AA, Emson P, Foord SM, and Marshall FH (1998) Heterodimerization is required for the formation of a functional GABA(B) receptor. Nature (Lond) 396:679-682.
135. Xiao RP, Pepe S, Spurgeon HA, Capogrossi MC, and Lakatta EG (1997) Opioid peptide receptor stimulation reverses beta-adrenergic effects in rat heart cells. Am J Physiol 272:H797-H805.
136. Xie Z, Lee SP, O'Dowd BF, and George SR (1999) Serotonin 5-HT1B and 5-HT1D receptors form homodimers when expressed alone and heterodimers when coexpressed. FEBS Lett 456:63-67.
137. Xu J, He J, Castleberry AM, Balasubramanian S, Lau AG, and Hall RA (2003) Heterodimerization of alpha 2A- and beta 1-adrenergic receptors. J Biol Chem 278:10770-10777.
138. Yoshioka K, Hosoda R, Kuroda Y, and Nakata H (2002a) Hetero- oligomerization of adenosine A1 receptors with P2Y1 receptors in rat brains. FEBS Lett 531:299-303.
139. Yoshioka K, Saitoh O, and Nakata H (2001) Heteromeric association creates a P2Y-like adenosine receptor. Proc Natl Acad Sci USA 98:7617-7622.
140. Yoshioka K, Saitoh O, and Nakata H (2002b) Agonist-promoted heteromeric oligomerization between adenosine A(1) and P2Y(1) receptors in living cells. FEBS Lett 523:147-151.
141. Zhao GQ, Zhang Y, Hoon MA, Chandrashekar J, Erlenbach I, Ryba NJ, and Zuker CS (2003) The receptors for mammalian sweet and umami taste. Cell 115:255-266.